Resmed Inc
RSMDF- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000943819
In the last 90 days, Resmed Inc insiders filed 0 open-market purchases and 4 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.17K in total; no superinvestor holds it.
Other share classesRMD
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 31, 2026, 1:11 AM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 7, 2026 | Jul 31, 2025 | Aug 1, 2024 | Aug 3, 2023 | Aug 11, 2022 |
| Revenue | $5.65B | $5.15B | $4.69B | $4.22B | $3.58B |
| Cost of revenue | $2.20B | $2.09B | $2.03B | $1.87B | $1.55B |
| Gross profit | $3.45B | $3.05B | $2.66B | $2.36B | $2.02B |
| Operating expenses | $1.57B | $1.37B | $1.34B | $1.22B | $1.02B |
| Research and development | $378.3M | $331.3M | $307.5M | $287.6M | $253.6M |
| Selling, general and administrative | $1.12B | $991.0M | $917.1M | $874.0M | $739.4M |
| Operating income | $1.89B | $1.69B | $1.32B | $1.13B | $1.00B |
| Income tax | $396.1M | $276.8M | $243.8M | $204.1M | $181.0M |
| Net income | $1.52B | $1.40B | $1.02B | $897.6M | $779.4M |
| EPS, basic | $10.47 | $9.55 | $6.94 | $6.12 | $5.34 |
| EPS, diluted | $10.43 | $9.51 | $6.92 | $6.09 | $5.30 |
| Weighted shares, basic | 145.5M | 146.7M | 147.0M | 146.8M | 146.1M |
| Weighted shares, diluted | 146.1M | 147.3M | 147.6M | 147.5M | 147.0M |
| Margins and growth | |||||
| Gross margin | 61.1% | 59.4% | 56.7% | 55.8% | 56.6% |
| Operating margin | 33.4% | 32.7% | 28.2% | 26.8% | 28.0% |
| Net margin | 26.9% | 27.2% | 21.8% | 21.3% | 21.8% |
| Revenue growth, year over year | +9.9% | +9.8% | +10.9% | +18.0% | +11.9% |
| Net income growth, year over year | +8.8% | +37.2% | +13.7% | +15.2% | +64.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 7, 2026 | Jul 31, 2025 | Aug 1, 2024 | Aug 3, 2023 | Aug 11, 2022 |
| Cash and equivalents | $1.47B | $1.21B | $238.4M | $227.9M | $273.7M |
| Accounts receivable | $1.04B | $939.5M | $837.3M | $704.9M | $576.0M |
| Inventory | $945.8M | $927.7M | $822.3M | $998.0M | $743.9M |
| Total current assets | $4.32B | $3.51B | $2.36B | $2.37B | $1.93B |
| Property, plant and equipment | $581.8M | $550.8M | $548.0M | $537.9M | $498.2M |
| Goodwill | $2.91B | $3.05B | $2.84B | $2.77B | $1.94B |
| Intangible assets | $452.7M | $464.9M | $485.9M | $552.3M | $345.9M |
| Total assets | $8.97B | $8.17B | $6.87B | $6.75B | $5.10B |
| Accounts payable | $308.9M | $278.2M | $237.7M | $150.8M | $159.2M |
| Short-term debt | $259.9M | $9.90M | $9.90M | $9.90M | $9.92M |
| Total current liabilities | $1.40B | $1.02B | $910.7M | $758.5M | $689.3M |
| Long-term debt | $399.4M | $658.4M | $697.3M | $1.43B | $765.3M |
| Total liabilities | $2.38B | $2.21B | $2.01B | $2.62B | $1.74B |
| Shareholders' equity | $6.59B | $5.97B | $4.86B | $4.13B | $3.36B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 7, 2026 | Jul 31, 2025 | Aug 1, 2024 | Aug 3, 2023 | Aug 11, 2022 |
| Operating cash flow | $1.81B | $1.75B | $1.40B | $693.3M | $351.1M |
| Capital expenditures | $156.3M | $89.9M | $99.5M | $119.7M | $134.8M |
| Free cash flow | $1.65B | $1.66B | $1.30B | $573.6M | $216.3M |
| Depreciation and amortization | $201.3M | $198.5M | $176.9M | $165.2M | $159.6M |
| Stock-based compensation | $104.3M | $91.7M | $80.2M | $71.1M | $65.3M |
| Dividends paid | $349.7M | $310.9M | $282.3M | $258.3M | $245.3M |
| Share buybacks | $700.0M | $300.0M | $150.0M | – | – |
| Investing cash flow | -$545.2M | -$200.0M | -$269.8M | -$1.16B | -$229.9M |
| Financing cash flow | -$1.01B | -$606.3M | -$1.12B | $422.9M | -$128.4M |
| Net change in cash | $259.8M | $971.1M | $10.5M | -$45.8M | -$21.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.8% | 1.8% | 1.7% | 1.7% | 1.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 26, 2026 | 140.7M | −3.6% | SEC |
| Aug 10, 2026 | 144.3M | −1.5% | SEC |
| Apr 27, 2026 | 145.1M | −1.1% | SEC |
| Jan 26, 2026 | 145.7M | −0.8% | SEC |
| Oct 27, 2025 | 146.0M | −0.6% | SEC |
| Aug 4, 2025 | 146.4M | −0.4% | SEC |
| Apr 21, 2025 | 146.6M | −0.2% | SEC |
| Jan 27, 2025 | 146.9M | −0.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.